RNAZ
RNAZ
NASDAQ · Biotechnology

Transcode Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks
$6.21
+0.97 (+18.51%)
As of Jun 30, 10:55 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +219.2% upside
Low Target $14.35
Average Target $19.82
High Target $27.60
Current Price $6.21
Current
$6.21
Target
$19.82
$14.35 $19.82 avg $27.60
Scenario Analysis
Bear Case
$14.35
131.1%
Low target
Base Case
$19.82
+219.2%
Avg target
Bull Case
$27.60
+344.4%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$20.99
-70.4% from high
52-Week Low
$3.82
+62.6% from low
Target vs 52W High
$19.82
-5.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -47.4%